Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lung Carcinoma”

385 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 385 results

Testing effectiveness (Phase 2)Ended earlyNCT04210037
What this trial is testing

Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ascentage Pharma Group Inc. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT00282022
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals 87
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Testing effectiveness (Phase 2)Ended earlyNCT02261805
What this trial is testing

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Who this might be right for
CancerSmall Cell Lung Cancer
Georgetown University 11
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Early research (Phase 1)Not Yet RecruitingNCT07351565
What this trial is testing

Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Chang Chen 22
Early research (Phase 1)Active Not RecruitingNCT05990738
What this trial is testing

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

Who this might be right for
Small Cell Lung Carcinoma (SCLC)
Boehringer Ingelheim 69
Testing effectiveness (Phase 2)Study completedNCT00634205
What this trial is testing

Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Lung Cancer Working Party 45
Early research (Phase 1)Active Not RecruitingNCT02998567
What this trial is testing

Combination Study of Guadecitabine/ASTX727 and Pembrolizumab

Who this might be right for
Non Small Cell Lung Cancer
Royal Marsden NHS Foundation Trust 60
Early research (Phase 1)Ended earlyNCT00976508
What this trial is testing

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsLung NeoplasmsBreast Neoplasms+2 more
Pfizer 24
Early research (Phase 1)Study completedNCT01134016
What this trial is testing

Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects

Who this might be right for
Non-small Cell Lung Cancer
Golden Biotechnology Corporation 13
Testing effectiveness (Phase 2)Study completedNCT00397293
What this trial is testing

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ascenta Therapeutics 36
Testing effectiveness (Phase 2)UnknownNCT01417806
What this trial is testing

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
South Florida Veterans Affairs Foundation for Research and Education 28
Very early researchUnknownNCT05180851
What this trial is testing

Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study

Who this might be right for
Head and Neck CancerMelanomaBreast Cancer+4 more
Shanghai Fengxian District Central Hospital 28
Testing effectiveness (Phase 2)Study completedNCT02531737
What this trial is testing

Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer

Who this might be right for
Lung Neoplasms
University Hospital, Limoges 59
Testing effectiveness (Phase 2)Study completedNCT00064012
What this trial is testing

Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 4
Testing effectiveness (Phase 2)UnknownNCT05265650
What this trial is testing

Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Clinica Universidad de Navarra, Universidad de Navarra 30
Not applicableNo Longer AvailableNCT05225259
What this trial is testing

Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor

Who this might be right for
Carcinoma, Non-Small-Cell LungThyroid Neoplasms
Eli Lilly and Company
Testing effectiveness (Phase 2)Ended earlyNCT02094560
What this trial is testing

CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors

Who this might be right for
Advanced Endstage Solid Carcinomas in Adults
CellAct Pharma GmbH 45
Load More Results